Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Crescent Biopharma CMO Ellie Eunkyung Im Sells $11.2K of Stock
Ellie Eunkyung Im, CMO, sold 623 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $11.2K in total on Sep 16, 2026. Shares held after the trade: 21,446 (-2.8%).
Crescent Biopharma President and COO Jonathan McNeill Sells $77.2K of Stock
Jonathan McNeill, President and COO, sold 4,570 shares of Crescent Biopharma, Inc. at $16.71 to $17.90 a share (average $16.90) in 2 transactions, worth $77.2K in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 134,588 (-2.8%).
Crescent Biopharma CFO Richard William Scalzo Sells $10.2K of Stock
Richard William Scalzo, CFO, sold 568 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $10.2K in total on Sep 16, 2026. Shares held after the trade: 19,730 (-2.8%).
Crescent Biopharma CEO Joshua T. Brumm Sells $160K of Stock
Joshua T. Brumm, CEO, sold 9,447 shares of Crescent Biopharma, Inc. at $16.71 to $17.90 a share (average $16.91) in 2 transactions, worth $160K in total between Sep 16, 2026 and Sep 18, 2026. Shares held after the trade: 271,765 (-2.8%).
Crescent Biopharma Insider Barbara Harlin Bispham Sells $11.1K of Stock
Barbara Harlin Bispham sold 620 shares of Crescent Biopharma, Inc. at $17.90 a share, worth $11.1K in total on Sep 16, 2026. Shares held after the trade: 18,710 (-3.2%).
Proto Labs CFO Daniel Schumacher Sells $418K of Stock
Daniel Schumacher, CFO, sold 4,900 shares of Proto Labs Inc at $85.21 a share, worth $418K in total on Sep 17, 2026. Shares held after the trade: 40,019 (-10.9%).
Mercury Systems received preliminary court approval for the settlement of two consolidated stockholder derivative actions, Jones v. Aslett and McKinnon v. Aslett. The settlement resolves litigation originally agreed upon in July 2026, with the court issuing formal orders granting preliminary approval on September 9 and September 15, 2026.
Counterparty
Essex County Superior Court for the Commonwealth of Massachusetts
Fuel Tech, Inc. has posted an updated corporate presentation to its website and filed it as an exhibit to this 8-K. The presentation, dated September 14, 2026, provides a strategic overview of the company's operations and technology for investors.
Omega Flex, Inc. declared a regular quarterly cash dividend of $0.34 per share for the third quarter of 2026. The dividend is payable on October 14, 2026, to shareholders of record as of the close of business on September 30, 2026.
KKR FS Income Trust issued and sold 127,341.992 Class I shares for approximately $3.705 million as part of its ongoing continuous private offering. The company also reported a net asset value (NAV) per share of $29.10 as of August 31, 2026, with total offering proceeds to date reaching approximately $1.769 billion.
Zoomcar Holdings, Inc. completed the sixth closing of its private placement of Series A units, raising approximately $155,000 in gross proceeds. Each unit, sold at $1,000, consists of one share of Series A Convertible Preferred Stock and a warrant to purchase 20,000 shares of common stock. The company has agreed to file a registration statement for the resale of the underlying common stock within 15 days of the closing.
Carlyle Credit Solutions declared a quarterly dividend of $0.14 per share for Class I common stock, payable on October 28, 2026. The company also disclosed it raised $10.3 million through the issuance of 569,592 shares as part of its ongoing continuous private offering and reported a net asset value (NAV) per share of $18.05 as of August 31, 2026.
Mesa Royalty Trust announced that there will be no cash distribution for the month of September 2026. The suspension is due to costs and expenses exceeding royalty revenues from its oil and gas properties, as well as the Trust's ongoing effort to build a $2.0 million cash reserve for liquidity.
Cemtrex Inc. announced that its Board of Directors has authorized the payment of a semi-annual dividend on its Series 1 Preferred Stock in the form of additional shares of the same stock. The dividend is based on a 10% annual rate on a $10.00 per share preference amount and will be issued on October 7, 2026, to shareholders of record as of September 30, 2026.
Pro-Dex, Inc. entered into a third amendment to its lease agreement with Irvine Business Properties for its executive offices and manufacturing facility in Irvine, California. The amendment extends the lease term to September 30, 2030, and establishes a schedule for 3.5% annual base rent increases starting in October 2027. This filing ensures the company maintains its primary operational and manufacturing footprint for the next four years.
Matthew Chretien retired as Chief Strategy Officer and Secretary effective September 1, 2026, and entered into a separation agreement providing three months' salary as severance. Joseph Spain, the current CFO and Treasurer, has assumed the additional role of Secretary while stepping down as Chief Operating Officer.
Inhibitor Therapeutics held its 2026 Annual Meeting of Stockholders on September 15, 2026, where shareholders elected six directors to the board for one-year terms. Stockholders also ratified Cherry Bekaert LLP as the independent auditor, approved the 2025 Share Incentive Plan, and approved executive compensation on an advisory basis.
North Haven Net REIT sold an aggregate of 216,664 Class I shares and 13,137 Class F-I shares to a feeder vehicle for approximately $4.8 million in total consideration. The private placement was conducted based on the company's net asset value per share as of August 31, 2026, and was exempt from registration under Rule 506 of Regulation D.
KKR FS Income Trust Select Capital Raise of $5.25M
KKR FS Income Trust Select issued and sold 211,475.523 Class I shares for approximately $5.255 million as part of its ongoing continuous private offering. As of September 18, 2026, the company has raised approximately $1.041 billion to date against a total offering target of $5.0 billion.
San Juan Basin Royalty Trust announced it will not declare a monthly cash distribution for September 2026. The suspension is due to excess production costs of approximately $12.55 million gross and continued low natural gas pricing. Distributions will remain suspended until net proceeds are sufficient to repay the excess costs, replenish a $2 million reserve, and repay the Trust's line of credit.
New Peoples Bankshares Insider John D. Cox Buys $58.8K of Stock
John D. Cox bought 12,000 shares of New Peoples Bankshares Inc at $4.90 a share, worth $58.8K in total on Sep 17, 2026. Shares held after the trade: 788,281 (+1.5%).
Cottonwood Communities, Inc. issued and sold 162,620 shares of its Series A Convertible Preferred Stock in a private placement offering between September 9 and September 17, 2026. The company received aggregate proceeds of $1.55 million from the sale, which is part of an ongoing private offering of up to $200 million. As of September 17, 2026, there were approximately 13.5 million shares of Series A Convertible Preferred Stock outstanding.
Community Bancorp. declared a quarterly cash dividend of $0.26 per share. The dividend is payable on November 1, 2026, to shareholders of record as of October 15, 2026.
Jennifer Gerold, the Chief Financial Officer of CreditRiskMonitor.com, Inc., has resigned for personal considerations effective November 17, 2026. Her departure is not due to any disagreement with the company, and she will remain in her role until the effective date to assist with the transition while a search for a replacement is conducted.
Nutex Health Insider Scott J. Saunders Sells $43.5K of Stock
Scott J. Saunders sold 203 shares of Nutex Health Inc. at $214.25 a share, worth $43.5K in total on Sep 18, 2026. Shares held after the trade: 400 (-33.7%).
Scorpio Tankers President Robert L. Bugbee Sells $22.2M of Stock
Robert L. Bugbee, President, sold 256,799 shares of Scorpio Tankers Inc. at $86.19 to $87.15 a share (average $86.28) in 2 transactions, worth $22.2M in total between Sep 16, 2026 and Sep 17, 2026. Shares held after the trade: 640,288 (+4.1%).
Exozymes Inc. has scheduled its 2026 Annual Meeting of Shareholders for November 13, 2026. The company established a record date of September 15, 2026, and plans to distribute proxy materials to shareholders on or about September 28, 2026.
PermRock Royalty Trust declared a monthly cash distribution of $238,742.30 ($0.0196242 per unit) payable on October 15, 2026, to holders of record as of September 30, 2026. The distribution is based on oil and natural gas production from the Trust's Permian Basin properties during the month of July 2026.
Ameren $900M Debt Financing with Barclays Capital Inc.
Ameren Corporation completed the sale of $900 million in Junior Subordinated Notes due 2057. The company received net proceeds of approximately $891 million before expenses to be used for general corporate purposes.
Value
$900M
Counterparty
Barclays Capital Inc., BofA Securities, Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc. and Truist Securities, Inc.